Feature | September 09, 2011 | David Shepard, M.D., Director of Medical Physics, Swedish Cancer Institute, Seattle, Wash.

Various Approaches to Delivering Dose

This article appeared as the introduction to a chart on arc-based radiotherapy systems in the September 2011 issue.

In radiation therapy, the use of rotational beam delivery provides greater flexibility in shaping radiation dose distributions.  When rotational delivery is combined with intensity modulated radiation therapy (IMRT), highly conformal dose distributions can be achieved with a rapid falloff in radiation damage outside of the target.

Tomotherapy is an arced approach to the delivery of IMRT that is characterized by the use of a binary multileaf collimator and the delivery of a fan beam of radiation.  The HiArt and TomoHD systems from TomoTherapy Inc. [Editor’s note: TomoTherapy was recently acquired by Accuray] are designed to deliver helical tomotherapy, a delivery technique where the linear accelerator is mounted on a ring-shaped gantry that progresses around the patient during the treatment.  The patient is slowly advanced through the rotating fan beam of radiation, leading to a helical beam delivery.  

Volumetric modulated arc therapy (VMAT) is an approach to rotational IMRT that can be delivered on a conventional linear accelerator.  VMAT combines the dosimetric advantages of rotational IMRT with a highly efficient delivery technique. Even complex IMRT plans can be delivered in a single arc with a delivery time under two minutes.

In 2008, both Varian and Elekta introduced linear accelerator control systems capable of delivering VMAT.  The new control software made it possible to simultaneously vary the multileaf collimator leaf positions, gantry rotation speed and dose rate during rotational beam delivery.  

The ability to deliver VMAT plans, however, only solved half of the problem.  The other challenge was the development of robust planning tools for VMAT.  

During the delivery of a VMAT arc, the positions of the multileaf collimator leaves are constantly changing.  Constraints must be imposed to limit the degree of leaf motion from one beam angle to the next.  This is necessary to ensure deliveries that are both accurate and efficient.  These leaf motion constraints are not easily incorporated into most optimization algorithms.  Consequently, many vendors have had to significantly rework their optimization tools to be able to support VMAT treatment planning.

The most widely implemented VMAT planning and delivery solution is Varian RapidArc.  RapidArc planning capabilities are available in Varian’s Eclipse treatment planning solution.  Eclipse uses direct aperture optimization (DAO) to create the optimized aperture shapes and weights.

Another widely used VMAT planning solution is the SmartArc module in Philips Medical’s Pinnacle3 treatment planning system.  The SmartArc module was developed by RaySearch Laboratories and relies on an aperture-based planning algorithm.  SmartArc is designed to perform VMAT planning for both Varian and Elekta linacs.  

One innovative feature with the SmartArc solution is the ability to deliver constant dose rate (CDR) VMAT.  With CDR VMAT, the dose rate remains constant throughout each arc while the MLC leaves move dynamically to achieve intensity modulation.  CDR VMAT plans can be delivered on many Varian linacs without the need to perform a RapidArc upgrade.  The disadvantage of CDR VMAT is that it removes a critical degree of freedom for the VMAT optimization.  Therefore, it may not be an ideal technique for the most complex IMRT cases.

The Nucletron Oncentra VMAT treatment planning solution was also developed by RaySearch Labs and consequently shares many similarities to the VMAT tools in Pinnacle.  Similar tools are also available in RaySearch’s own treatment planning system, called RayStation.

Elekta now offers VMAT planning in its Monaco treatment planning solution.  Monaco employs an arc sequencing algorithm rather than using an aperture-based optimization.  With an arc sequencer, VMAT plans are produced using a two-step process.  First, an optimized fixed-field IMRT plan is developed.  A sequencing algorithm is then applied that converts the fixed-field IMRT plan into one that can be delivered using VMAT.

The most robust VMAT planning solutions provide the ability to plan single-arc and multi-arc deliveries, non-coplanar arcs and constant dose rate VMAT.  The quality of VMAT planning and delivery are continuing to improve, and more and more clinics are taking advantage of this treatment technique.

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Lung Decision Precision
News | Lung Cancer | June 04, 2018
For smokers and former smokers, the threat of lung cancer always lurks in the shadows.
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
Overlay Init